Indexed logomarkindexed.vc

XyloCor Therapeutics

Biotech
Healthcare
Headquarters
King of Prussia, Pennsylvania
Website
xylocor.com

About

XyloCor Therapeutics is a development-stage biotechnology company developing gene therapies for advanced coronary artery disease and refractory angina.

Summary

XyloCor Therapeutics is a Biotech company based in King of Prussia, United States.

LinkedIn

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022

Appears in

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

XyloCor Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/xylocor-therapeutics"><img src="https://indexed.vc/api/badge/company/xylocor-therapeutics" alt="XyloCor Therapeutics on Indexed.vc" width="260" height="76" /></a>